Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanuja Shet

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2022
Long-Term Clinical Outcomes and Sequelae of Therapy in Early-Stage Orbital Mucosa-Associated Lymphoid Tissue LymphomaGoutam Panda, Babusha Kalra, Anupam Rishi, et al.
The Indian Journal of Medical Research|September 18, 2010
Assessment of HER-2/neu status in breast cancer using fluorescence in situ hybridization & immunohistochemistry: Experience of a tertiary cancer referral centre in IndiaPoonam Panjwani, Sridhar Epari, Arti Karpate, et al.
Leukemia & Lymphoma|December 21, 2013
Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?Siddhartha Laskar, Deepak P Kumar, Nehal Khanna, et al.
Pediatric Hematology and Oncology|February 18, 2022
Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in IndiaKalasekhar Vijayasekharan, Anand Kc, Maya Prasad, et al.
Cancer Research Communications|February 5, 2024
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast CancerNilesh Gardi, Rohan Chaubal, Pallavi Parab, et al.
British Journal of Haematology|May 21, 2025
Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphomaShyam Srinivasan, Aditya Narayan, Chetan Dhamne, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 16, 2021
Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre ExperienceHasmukh Jain, Akhil Kapoor, Manju Sengar, et al.
Journal of Adolescent and Young Adult Oncology|October 22, 2020
Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in IndiaLingaraj Nayak, Hasmukh Jain, Avinash Bonda, et al.
Leukemia & Lymphoma|August 21, 2023
Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL)Akhil Rajendra, Manju Sengar, V N Avinash Bonda, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2022
"Diffuse Large B-Cell Lymphoma in the Elderly: Real-World Outcomes From a Developing Country"Kunal Jobanputra, Lingaraj Nayak, Hasmukh Jain, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2022
Long-Term Clinical Outcomes and Sequelae of Therapy in Early-Stage Orbital Mucosa-Associated Lymphoid Tissue LymphomaGoutam Panda, Babusha Kalra, Anupam Rishi, et al.
The Indian Journal of Medical Research|September 18, 2010
Assessment of HER-2/neu status in breast cancer using fluorescence in situ hybridization & immunohistochemistry: Experience of a tertiary cancer referral centre in IndiaPoonam Panjwani, Sridhar Epari, Arti Karpate, et al.
Leukemia & Lymphoma|December 21, 2013
Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?Siddhartha Laskar, Deepak P Kumar, Nehal Khanna, et al.
Pediatric Hematology and Oncology|February 18, 2022
Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in IndiaKalasekhar Vijayasekharan, Anand Kc, Maya Prasad, et al.
Cancer Research Communications|February 5, 2024
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast CancerNilesh Gardi, Rohan Chaubal, Pallavi Parab, et al.
British Journal of Haematology|May 21, 2025
Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphomaShyam Srinivasan, Aditya Narayan, Chetan Dhamne, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 16, 2021
Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre ExperienceHasmukh Jain, Akhil Kapoor, Manju Sengar, et al.
Journal of Adolescent and Young Adult Oncology|October 22, 2020
Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in IndiaLingaraj Nayak, Hasmukh Jain, Avinash Bonda, et al.
Leukemia & Lymphoma|August 21, 2023
Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL)Akhil Rajendra, Manju Sengar, V N Avinash Bonda, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2022
"Diffuse Large B-Cell Lymphoma in the Elderly: Real-World Outcomes From a Developing Country"Kunal Jobanputra, Lingaraj Nayak, Hasmukh Jain, et al.
Pageof 18